Michael J Domanski
Overview
Explore the profile of Michael J Domanski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
2682
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Domanski M, Wu C, Tian X, Hasan A, Ma X, Huang Y, et al.
J Am Coll Cardiol
. 2023 Mar;
81(12):1151-1161.
PMID: 36948731
Background: The quantitative relationship of incident cardiovascular disease (CVD) to lifetime cumulative risk factor exposure is not well understood. Objectives: Using CARDIA (Coronary Artery Risk Development in Young Adults) study...
2.
Reges O, Ning H, Wilkins J, Wu C, Tian X, Domanski M, et al.
Hypertension
. 2020 Dec;
77(2):347-356.
PMID: 33342241
Hypertension is a major risk factor for cardiovascular disease (CVD), but previous studies have mostly been limited to a single exam, a single cohort, a short follow-up period, or a...
3.
Domanski M, Tian X, Wu C, Reis J, Dey A, Gu Y, et al.
J Am Coll Cardiol
. 2020 Sep;
76(13):1507-1516.
PMID: 32972526
Background: Incident cardiovascular disease (CVD) increases with increasing low-density lipoprotein cholesterol (LDL-C) concentration and exposure duration. Area under the LDL-C versus age curve is a possible risk parameter. Data-based demonstration...
4.
5.
Domanski M, Farkouh M
Circulation
. 2018 Nov;
138(19):2079-2080.
PMID: 30474419
No abstract available.
6.
Head S, Milojevic M, Domanski M, Farkouh M, Kappetein A
J Am Coll Cardiol
. 2018 Nov;
72(21):2681.
PMID: 30466530
No abstract available.
7.
Head S, Milojevic M, Daemen J, Ahn J, Boersma E, Christiansen E, et al.
J Am Coll Cardiol
. 2018 Jul;
72(4):386-398.
PMID: 30025574
Background: Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) are used for coronary revascularization in patients with multivessel and left main coronary artery disease. Stroke is among the...
8.
Hicks K, Mahaffey K, Mehran R, Nissen S, Wiviott S, Dunn B, et al.
J Am Coll Cardiol
. 2018 Mar;
71(9):1021-1034.
PMID: 29495982
This publication describes uniform definitions for cardiovascular and stroke outcomes developed by the Standardized Data Collection for Cardiovascular Trials Initiative and the U.S. Food and Drug Administration (FDA). The FDA...
9.
Hicks K, Mahaffey K, Mehran R, Nissen S, Wiviott S, Dunn B, et al.
Circulation
. 2018 Feb;
137(9):961-972.
PMID: 29483172
This publication describes uniform definitions for cardiovascular and stroke outcomes developed by the Standardized Data Collection for Cardiovascular Trials Initiative and the US Food and Drug Administration (FDA). The FDA...
10.
Head S, Milojevic M, Daemen J, Ahn J, Boersma E, Christiansen E, et al.
Lancet
. 2018 Feb;
391(10124):939-948.
PMID: 29478841
Background: Numerous randomised trials have compared coronary artery bypass grafting (CABG) with percutaneous coronary intervention (PCI) for patients with coronary artery disease. However, no studies have been powered to detect...